Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Calgary
$27,000.00
Predicting Growth Hormone Deficiency in Adult Traumatic Brain Injury
FY 2025-26
Summary
Thousands of Canadians sustain a traumatic brain injury (TBI) each year, often leading to persisting symptoms such as tiredness, poor sleep, and problems with memory and thinking. Up to 40% of adults with persistent symptoms following a TBI develop growth hormone deficiency (GHD), which develops when the parts of the brain that control hormone release are affected during injury. However, GHD often goes undetected because these symptoms are very similar to common TBI symptoms. Unfortunately, the test used to diagnose GHD is timely, expensive, and only available at specific centres, leading to wait times of several months. This study will follow 300 adults with persisting symptoms one year or more after their TBI. All participants will complete online questionnaires about their tiredness, sleep, mood, and daily functioning, along with brief cognitive tests of attention, memory, and processing speed. Participants will then undergo the standard hormone test for GHD. A small subgroup will also use a sleep monitor at home and complete an overnight sleep study to measure sleep quality, restful sleep, and an active dreaming stage of sleep important for memory. We will compare people with and without GHD to identify symptom patterns, sleep features, and cognitive differences most strongly linked to GHD after TBI, if any. This research has the potential to provide clinicians with clearer, evidence-based indicators of who is most likely to have GHD and identify who should be prioritized for hormone testing, leading to more efficient referrals and shorter wait times for testing. Earlier identification and treatment of GHD may ultimately improve energy levels, sleep quality, thinking and overall quality of life for people living with long-term effects of TBI.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573310
Name
Tanweer Mahrukh
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting Growth Hormone Deficiency in Adult Traumatic Brain Injury
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cognitive Impairment; Early Detection; Endocrine Dysfunction; Fatigue; Glucagon Stimulation Test; Growth Hormone Deficiency; Quality Of Life; Sleep Disturbances; Symptom-Based Screening; Traumatic Brain Injury
Abstract
Thousands of Canadians sustain a traumatic brain injury (TBI) each year, often leading to persisting symptoms such as tiredness, poor sleep, and problems with memory and thinking. Up to 40% of adults with persistent symptoms following a TBI develop growth hormone deficiency (GHD), which develops when the parts of the brain that control hormone release are affected during injury. However, GHD often goes undetected because these symptoms are very similar to common TBI symptoms. Unfortunately, the test used to diagnose GHD is timely, expensive, and only available at specific centres, leading to wait times of several months. This study will follow 300 adults with persisting symptoms one year or more after their TBI. All participants will complete online questionnaires about their tiredness, sleep, mood, and daily functioning, along with brief cognitive tests of attention, memory, and processing speed. Participants will then undergo the standard hormone test for GHD. A small subgroup will also use a sleep monitor at home and complete an overnight sleep study to measure sleep quality, restful sleep, and an active dreaming stage of sleep important for memory. We will compare people with and without GHD to identify symptom patterns, sleep features, and cognitive differences most strongly linked to GHD after TBI, if any. This research has the potential to provide clinicians with clearer, evidence-based indicators of who is most likely to have GHD and identify who should be prioritized for hormone testing, leading to more efficient referrals and shorter wait times for testing. Earlier identification and treatment of GHD may ultimately improve energy levels, sleep quality, thinking and overall quality of life for people living with long-term effects of TBI.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tanweer, Mahrukh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~